Lv1
50 积分 2026-01-28 加入
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
45分钟前
待确认
Renal Cell Carcinoma
47分钟前
已完结
Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer
5天前
已完结
Liver transplantation for acute liver failure in Europe: Outcomes over 20years from the ELTR database
1个月前
已完结
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial
2个月前
已完结
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
2个月前
已完结
DB-1311/BNT324 (a novel B7H3 ADC) in patients with heavily pretreated castrate-resistant prostate cancer (CRPC)
2个月前
已完结
Effectiveness of trastuzumab deruxtecan rechallenge in a patient with HER2-positive metastatic breast cancer: a case report
2个月前
已完结
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study
3个月前
已完结
皖公网安备34019202002308
